|
||||||||||||||||
|
||||||||||||||||
| HUM-MOLGEN -> Events | Search | Write an announcement | ||||||||||||||||
Meetings and Conferences by date |
||||||||||||||||
| June, 15 2026 |
your calendar for events in
genetics, biotechnology and medicine |
|||||||||||||||
| June 2026 | 2026-06-17 Others: Early decisions can either accelerate or undermine the success of advanced therapy programs. From product conception through clinical and commercial scale, proactive planning is essential, especially Prevent Advanced Therapy Program Delays with Early Supply Chain Strategy |
Xtalks — The Life Science Community™, Online webinar | ||||||||||||||
| 2026-06-23 Microbiology / Virology: Digitally enabled FSP models are changing how clinical trials and development programs are planned, staffed and executed across the life sciences industry. As sponsors face pressure to start studies f Improve Trial Readiness with Tech-Enabled FSP Delivery Models |
Xtalks — The Life Science Community™, Online webinar | |||||||||||||||
| 2026-06-24 Others: Despite two decades of technological advancement, the debate between paper and electronic clinical outcome assessments (eCOA) remains surprisingly unresolved, even with the available evidence. This we eCOA: Has It Lived Up to the Promise? A Realistic Assessment for Today's Trials |
Xtalks — The Life Science Community™, Online webinar | |||||||||||||||
| 2026-06-30 Neurology / Neuroscience: Precision medicine is redefining what’s clinically possible, but not what’s commercially guaranteed. In the US, biomarker-driven and companion diagnostic–led therapies face persistent access barriers, From Biomarker to Market: Optimizing Access for Precision Therapies |
Xtalks — The Life Science Community™, Online webinar | |||||||||||||||
| July 2026 | Boston, MA Gene Therapy: 3rd Global Cell and Gene Therapy Summit 3rd Global Cell and Gene Therapy Summit |
USG, Four Points by Sheraton Wakefield Boston Hotel & Conference Center | ||||||||||||||
| 2026-07-22 Others: Medical Information (MI), Pharmacovigilance (PV) and Regulatory Affairs (RA) each play distinct but deeply interconnected roles in ensuring that therapeutics are safe, accurately labeled and compliant How MI, PV & Regulatory Collaborate on Signals, Labeling, Crisis Response and AI |
Xtalks — The Life Science Community™, Online webinar | |||||||||||||||
| October 2026 | 06-08 October 2026 Cancer Research: 5th edition EACR Cancer Metabolism |
The European Association for Cancer Research (EACR), Bilbao, Spain | ||||||||||||||
| 15/10/2026 to 17/10/2026 Others: 23rd Continuing Professional Development (CPD) Series Diabetes Asia 2026 Conference (DAC 2026) |
National Diabetes Institute, voco Kuching by IHG, Kuching, Sarawak, Malaysia | |||||||||||||||
|
||||||||||||||||
|
Generated by meetings and positions 5.0 by Kai Garlipp |
||||||||||||||||